StockData
Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc. (AKBA) stock

AKBANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.45−0.03 (-5.40%)

Close on Nov 16, 2026Market cap $124.31MP/E –Yield –

Akebia Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Akebia Therapeutics's total debt was $49.56M at Jun 30, 2026. For fiscal 2025 it was $48.25M, up 24.7% from the year before. The highest annual figure on record is $97.54M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.25M+24.7%
FY2024Dec 31, 2024$38.69M+11.6%
FY2023Dec 31, 2023$34.68M-47.5%
FY2022Dec 31, 2022$66.08M-32.3%
FY2021Dec 31, 2021$97.54M+1.2%
FY2020Dec 31, 2020$96.38M+27.1%
FY2019Dec 31, 2019$75.81M+405.4%
FY2018Dec 31, 2018$15.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$49.56M+5.3%
Q1 FY2026Mar 31, 2026$48.89M+5.1%
Q4 FY2025Dec 31, 2025$48.25M+24.7%
Q3 FY2025Sep 30, 2025$47.64M+24.2%
Q2 FY2025Jun 30, 2025$47.06M+23.7%
Q1 FY2025Mar 31, 2025$46.51M+54.3%
Q4 FY2024Dec 31, 2024$38.69M+11.6%
Q3 FY2024Sep 30, 2024$38.36M-10.0%
Q2 FY2024Jun 30, 2024$38.03M-10.5%
Q1 FY2024Mar 31, 2024$30.15M-40.1%
Q4 FY2023Dec 31, 2023$34.68M-47.5%
Q3 FY2023Sep 30, 2023$42.61M-35.4%
Q2 FY2023Jun 30, 2023$42.49M-56.7%
Q1 FY2023Mar 31, 2023$50.30M-48.6%
Q4 FY2022Dec 31, 2022$66.08M-32.3%
Q3 FY2022Sep 30, 2022$65.95M-32.2%
Q2 FY2022Jun 30, 2022$98.16M+1.3%
Q1 FY2022Mar 31, 2022$97.85M+1.3%
Q4 FY2021Dec 31, 2021$97.54M+1.2%
Q3 FY2021Sep 30, 2021$97.23M+26.9%
Q2 FY2021Jun 30, 2021$96.92M+27.0%
Q1 FY2021Mar 31, 2021$96.61M+27.0%
Q4 FY2020Dec 31, 2020$96.38M+27.1%
Q3 FY2020Sep 30, 2020$76.61M+410.7%
Q2 FY2020Jun 30, 2020$76.34M–
Q1 FY2020Mar 31, 2020$76.07M–
Q4 FY2019Dec 31, 2019$75.81M–
Q4 FY2018Dec 31, 2018$15.00M–

More Akebia Therapeutics figures

See a number that looks wrong?